Zydus Lifesciences launched Tishtha™, the world’s first Nivolumab biosimilar in India, offering affordable cancer treatment and expanding access to advanced immuno-oncology therapies.
Zydus Lifesciences launched Tishtha™, the world’s first Nivolumab biosimilar in India, offering affordable cancer treatment and expanding access to advanced immuno-oncology therapies.